Abstract
Tuberculosis is one of the leading causes of morbidity and mortality worldwide. Current treatment has several challenges, such as multi-drug resistance, extensively drug-resistance and HIV co-infection. Problems related to patients, treatment and health care system also contribute negatively to this panel. This review summarizes the main obstacles causing in the treatment of tuberculosis and discusses several strategies to improve the treatment.
Keywords: Drug interactions, extensively drug-resistance, HIV, multi-drug resistance, treatment improvement, tuberculosis, tuberculosis treatment.
Current Clinical Pharmacology
Title:Tuberculosis: Challenges to Improve the Treatment
Volume: 10 Issue: 3
Author(s): Mariana Moreira Lima, Ariane Trindade, Flávia Carnavalli, Aylime Castanho Bolognesi Melchior, Chung Man Chin and Jean Leandro dos Santos
Affiliation:
Keywords: Drug interactions, extensively drug-resistance, HIV, multi-drug resistance, treatment improvement, tuberculosis, tuberculosis treatment.
Abstract: Tuberculosis is one of the leading causes of morbidity and mortality worldwide. Current treatment has several challenges, such as multi-drug resistance, extensively drug-resistance and HIV co-infection. Problems related to patients, treatment and health care system also contribute negatively to this panel. This review summarizes the main obstacles causing in the treatment of tuberculosis and discusses several strategies to improve the treatment.
Export Options
About this article
Cite this article as:
Lima Moreira Mariana, Trindade Ariane, Carnavalli Flávia, Bolognesi Melchior Castanho Aylime, Chin Man Chung and dos Santos Leandro Jean, Tuberculosis: Challenges to Improve the Treatment, Current Clinical Pharmacology 2015; 10 (3) . https://dx.doi.org/10.2174/1574884708666131229124215
DOI https://dx.doi.org/10.2174/1574884708666131229124215 |
Print ISSN 1574-8847 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3938 |
Related Articles
-
SV40 and HIV Sequences in the Cerebrospinal Fluid of a Patient with AIDS Dementia Complex
Current HIV Research New Pyrrole Hydrazones Synthesized and Evaluated In Vitro as Potential Tuberculostatics
Letters in Drug Design & Discovery Green Formation of Novel Pyridinyltriazole-Salicylidene Schiff Bases
Current Organic Synthesis Molecules of Infectious Agents as Immunomodulatory Drugs
Current Topics in Medicinal Chemistry Adenosine and Adenosine Receptors in the Pathomechanism and Treatment of Respiratory Diseases
Current Medicinal Chemistry Recent Advances in Clinical Immunology, Endocrine & Metabolic Drugs: An Editorial Overview
Clinical Immunology, Endocrine & Metabolic Drugs (Discontinued) Prevalence of Adverse Drug Reactions to Highly Active Antiretroviral Therapy (HAART) among HIV Positive Patients in Imam Khomeini Hospital of Tehran, Iran
Infectious Disorders - Drug Targets Dendritic Cells in Innate Immune Responses Against HIV
Current Molecular Medicine Dietary Antioxidants: Immunity and Host Defense
Current Topics in Medicinal Chemistry Early Hospital Readmission in Patients With Tuberculosis: Social and Cultural Risk Factors
Current Respiratory Medicine Reviews Formulation of Rifampicin Loaded PEGylated 5.0G EDA-PAMAM Dendrimers as Effective Long-Duration Release Drug Carriers
Current Drug Therapy Recent Updates in Imperative Natural Compounds for Healthy Brain and Nerve Function: A Systematic Review of Implications for Multiple Sclerosis
Current Drug Targets Neopterin as a Marker for Immune System Activation
Current Drug Metabolism Listeria monocytogenes as a Vector for Anti-Cancer Therapies
Current Gene Therapy Global Clinical Trials for the Treatment of TB with Thioridazine
Recent Patents on Anti-Infective Drug Discovery Polysaccharide-synthesizing Glycosyltransferases and Carbohydrate Binding Modules: the case of Starch Synthase III
Protein & Peptide Letters Noninvasive Assessment of Cytokines in Occupational Respiratory Diseases
Recent Patents on Inflammation & Allergy Drug Discovery Conducting HIV Seroprevalence and Behavioral Epidemiology Risk Surveys (SABERS) Among Partner Military Populations
Current HIV Research New Anti-Tuberculosis Drugs with Novel Mechanisms of Action
Current Medicinal Chemistry Oxazolidinone Antibacterials and Our Experience
Anti-Infective Agents in Medicinal Chemistry